Curriculum

POSITION: Associate Professor on the SSD MEDS-25/A (ex MED/43), Legal Medicine, at the Department of Translational Medicine of the University of Ferrara, Italy. He also has the achievement of the national scientific qualification for the role of Associate Professor for 05/G1 Pharmacology, Clinical Pharmacology and Pharmacognosy on the SSD BIO/14-Pharmacology.

 

ROLE: Director of the Laboratory of Forensic Toxicology and Clinical Xenobiocinetics of the University of Ferrara.

 

SCIENTIFIC ASSIGNMENT: National scientific member for the Multicentric Research Team on NPS study and for the enhancement of the National Early Warning System, established by the Anti-Drug Policies Department (DPA), Presidency of the Council of Ministers (PCM), Italy.

 

SCIENTIFIC PROFILE

- July 1996. Degree in Pharmaceutical Chemistry and Technology with discussion of the following experimental work: “Cholinergic modulation of glutamate release from rat striatal slices.”

- April-October 2000. Research internship in electrophysiology at the Department of Neuroscience, Neurological Clinic (Prof. Paolo Calabresi), University of Rome “Tor Vergata,” Rome, Italy.

- January 2001. PhD in “Molecular and Cellular Pharmacology,” Faculty of Medicine, Department of Clinical and Experimental Medicine. Thesis title: “Alterations of striatal glutamatergic transmission in a model of Parkinson's disease. In vitro and in vivo studies.”

- July 2002-2006. Served as a research fellow at the Department of Clinical and Experimental Medicine, Pharmacology Section, University of Ferrara. Research title: “Study of alterations in striatal glutamatergic transmission in experimental models of movement disorders: Parkinson's Disease and Huntington's Disease.”

- August 6, 2006 - July 31, 2009. He was a research associate at the Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Ferrara. Research title: “Receptor ligands for nociceptin/orphanin FQ in the treatment of Parkinson's disease.”

- From December 6, 2010 to May 5, 2013, he held a research grant at IRCSS, Santa Lucia Foundation, Rome. The project funded by the Ministry of Health under the program “Young Researchers 2008” entitled “Modulation of NMDA receptor composition in a model of early parkinsonism and L-DOPA-induced dyskinesia: new therapeutic strategy”.

- Since 2000. He is a collaborator and consultant to police forces (RIS Carabinieri, Police, DCSA) and various national associations for the study of NPS and psychoactive substance use in criminogenic and sectarian contexts.

- Since 2010, he has initiated preclinical pharmaco-toxicological studies on New Psychoactive Substances in collaboration with national and international institutions.

- From 2012 to present coordinates one of the collaborating centers of the National Early Warning and Rapid Drug Response System of the DPA of the Presidency of the Council of Ministers, Italy.

- From 1/9/2012 to 31/8/2017 university researcher (RTD-A; art.24, no.240) on SSD BIO/14, at the Department of Life Sciences and Biotechnology (SVeB).

- October 2012. Postgraduate Diploma in “Multidisciplinary Training on Addictions” (Decree 290/2012 of the President of the Higher School of Public Administration) at the School on Addictions of the DPA, Presidency of the Council of Ministers.

- September 2013. Postgraduate Diploma in “Multidisciplinary Training on Addictions,” advanced course at the National School of Administration and School on Addictions of the DPA (PCM).

- From 1/9/2018 to 31/8/2020 University Researcher (RTD-B; art.24, no.240) on SSD MED/43, at the Department of Morphology, Surgery and Experimental Medicine.

- Oct. 1-2, 2014. Posted to Lisbon as part of the European Research Area Network on Illicit Drugs (ERANID) for the Department of Anti-Drug Policies of the Presidency of the Council of Ministers.

- November 17-18, 2014. Was sent as an expert by the Italian DPA's Early Warning System for the European Commission TAIEX for the formation of the Croatian government's Early Warning System in Zagreb.

- 2018 to 2021 national scientific coordinator of the multicenter research group (“Effects of NPS: development of a multicenter research for information enhancement of the Early Warning System”) established by DPA.

- 2019 to present, member of DPA's inter-institutional technical table for emergency on opioid substances and fentanyl derivatives.

- 2023 to present, member of DPA's Italian Expert Panel for the committee established by the U.S. White House for the Global Coalition to Address Synthetic Drug Threats.

 

ACCADEMIC PROFILE

  • From 2005 to 2012 he teaches "Toxicology" at the Faculty of Pharmacy of the University of Ferrara.
  • 2012 member of the Academic Council of the PhD in Pharmacology and Molecular Oncology of the University of Ferrara.
  • From 2012 to 2020 he teaches "Toxicology and pharmacological methods" in the course of studies of Chemistry and Pharmaceutical Technology at the University of Ferrara.
  • 2020 to today member of the Academic Council of the PhD in Advanced Therapies and Experimental Pharmacology of the University of Ferrara.
  • From 2019 to today he teaches "Forensic Medicine" in the Master’s Degree in Medicine and Surgery at the University of Ferrara.
  • From 2019 to today he teaches "Techniques of Pharmacology and Toxicology" in the Bachelor’s Degree in Biomedical Laboratory Techniques at the University of Ferrara.
  • From 2020 to today he teaches "Forensic Medicine and Pharmacology" in the course of Motor Sciences at the University of Ferrara.
  • From 2022 to today he teaches "Biotechnology applied to forensic sciences" in the Master’s Degree in Biotechnology for translational medicine at the University of Ferrara.

 

Prof Marti has held more than 70 oral communications as an invited speaker at national and international conferences.

 

Prof Marti has held more than 70 oral communications as an invited speaker at national and international conferences.

Principal Investigator (PI) or Head of Unit (HU) in National and European projects

  • 2024-2025: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers and Direzione Centrale per i Servizi Antidroga (DCSA): "Implementation of an initiative, on an experimental basis, to support the systematic carrying out of toxicological examinations on narcotics seized by the Police Force within the framework of the administrative proceedings pursuant to Article 75 of Presidential Decree No. 309 of 1990, in order to detect the presence of fentanyl and other synthetic opioids in the ‘street doses’ circulating in the national nationwide”. (PI)
  • 2024-2025: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: " Implementation of new information flows for the collection of data on drugs circulating on Italian territory to enhance the effectiveness and operational efficiency of the National Early Warning System". (PI)
  • 2023-2025: Project PRIN 2022 funded by the Italian Ministry of the University and Research: “Shedding new lights on the emerging New Synthetic Opioids of "Nitazene" class: a Multidisciplinary Pharmaco-toxicological and Analytical approach towards forensic investigation (NSO_MAP)”. (PI)
  • 2022-2024: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: "Implementation of the identification and study of the effects of NPS: Development of a multicentric research to strengthen the database of the National Monitoring Centre for Drug Addiction and the Early Warning System". (HU)
  • 2023-2024: Research Project of ICS Maugeri Pavia, "In vitro and in vivo evaluation of the toxicity of new synthetic and/or natural psychoactive substances (NSP), with particular focus on pharmacotoxicological, histopathological/ultrastructural effects and on the Pathways of cell death and neurotransmission, in order to develop effective therapeutic strategies in emergency/urgency". (HU)
  • FAR 2023: "Multidisciplinary in vitro and in vivo study of the pharmaco-toxicological effects of New Psychoactive Substances (NSP) on motor, sensory, neurological, cardiovascular and respiratory functions of rodents and comparison with the zebrafish larva model". (PI)
  • FAR 2022: "Multidisciplinary in vitro and in vivo study of the pharmaco-toxicological effects of New Psychoactive Substances (NSP) on motor, sensory, neurological, cardiovascular and respiratory functions of rodents and comparison with the zebrafish larva model". (PI)
  • 2018-2022: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: "Effects of NPS: Development of a multicenter research for the information enhancement of the Early Warning System". (PI)
  • 2020-2021: Research Project of ICS Maugeri Pavia, "Multidisciplinary study of the pharmaco-toxicological and pathophysiological effects of new psychoactive INSPI substances of synthetic and/or natural derivation, to understand possible emergency therapeutic strategies". (HU)
  • FAR 2021: "Multidisciplinary in vitro and in vivo study of the pharmaco-toxicological effects of New Psychoactive Substances (NSP) on motor, sensory, neurological, cardiovascular and respiratory functions of rodents and comparison with the zebrafish larva model". (PI)
  • FAR 2020: "Multidisciplinary in vitro and in vivo study of the pharmaco-toxicological effects of New Psychoactive Substances (NSP) on motor, sensory, neurological, cardiovascular and respiratory functions of rodents and comparison with the zebrafish larva model". (PI)
  • FAR 2019: "Multidisciplinary study of the pharmaco-toxicological effects of new psychoactive substances (NSP)". (PI)
  • 2017-2019: Research Project of ICS Maugeri Pavia, "Multidisciplinary study of the pharmaco-toxicological and pathophysiological effects of new psychoactive INSPI substances of synthetic and / or natural derivation, to understand possible emergency therapeutic strategies". (PI)
  • FAR 2017: "Multidisciplinary study of the pharmaco-toxicological effects of new psychoactive substances (NSP)". (PI)
  • FAR 2016: "Multidisciplinary study of the pharmaco-toxicological and pathophysiological effects of new synthetic psychoactive molecules". (PI)
  • 2015-2016 European Project EUMadness (EUropean-wide, Monitoring, Analysis and knowledge Dissemination on Novel / Emerging Psychoactives) for the monitoring, study and assessment of human health risks caused by New Psychoactive Substances. (Required as an expert for the research activities of the project).
  • 2014-2017: Project funded by the Department of Anti-drug Policies by the Presidency of the Council of Ministers: NS-Drugs Project, multidisciplinary study of the pharmaco-toxicological and pathophysiological effects of new synthetic psychoactive molecules (Novel Synthetic Drugs, NS-Drugs) to understand possible psycho alterations -physicals in car drivers. (PI)
  • 2014-2017: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: NPS-TOX project, Animal model toxicology study on New Psychoactive Substances (NPS) according to GLP procedures with a view to setting up methods for assessing associated road accidents to NPS. (co-PI)
  • 2014-2016: Project funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: INSIDE-018 Project, Preclinical multidisciplinary project for the characterization of acute and chronic effects on the central nervous system of the synthetic cannabinoid JWH-018. (HU)
  • 2012-2015 VARD Project, funded by the Department of Anti-Drug Policies by the Presidency of the Council of Ministers: Project to assess the prevalence of use of date rape drugs, develop and validate sensitive and reliable analytical methods, define procedures and good practices in this regard to get to the drafting and dissemination of technical-scientific guidelines. (Required as an expert for the research activities of the project)
  • FAR 2014: “Partial NOP receptor agonists and neuropsychiatric diseases”. (PI)
  • FAR 2013: “Partial NOP receptor agonists and neuropsychiatric diseases”. (PI)
  • FIRB 2012 - "Future in Research" Program: "project" The abuse/addiction to anabolics and new psychoactive substances (Smart Drugs) as a social scourge of health and legal interest. Organ damage in the youth sports population: epidemiological, biochemical, pathological, toxicological evidence and control mechanisms". (HU)
  • FIRB 2010-2013. Funding from the Ministry of Health for young researchers  "NMDA receptor modulation in early Parkinsonism and in L-Dopa-induced dyskinesia: a new therapeutic strategy". (HU)
  • MURST, 1999-2000, Funding for young researchers, "Somatostatin and NPY implications in the Temporal Lobe Epilepsy". (PI)

 

 

Prof. Marti is the owner of the following Patents:

  • “NOP receptor antagonists and their therapeutic uses”; n ° MI2003A001349, filed on 1 July 2003. Inventors M Morari, M Marti; assignee UFPeptides.
  • International extension PCT / EP / 2004/006826 filed on June 24, 2004 (NOP receptor antagonists and therapeutic uses thereof). Inventors M Morari, M Marti; assignee UFPeptides.
  • “NOP receptor agonists for the treatment of levodopa-induced dyskinesias; n ° FE2006A000036 filed on November 23, 2006. Inventors M Morari, M Marti; assignee UFPeptides.
  • International Extension n. PCT / IB2007 / 003597 filed November 23, 2007 (NOP receptor antagonists for the treatment of L-DOPA induced dyskinesias). Inventors M Morari, M Marti; assignee University of Ferrara.

 

Prof. Marti participated in the patenting of a system for the study of startle/PPI in rodents for Ugo Basile. The study carried out by Prof. Marti is part of the patent for a new application for the behavioral assessment in rodents of the effects of new narcotic and psychoactive substances on sensory gating. Active from 02-11-2016 to today.

International Pubblications

Bibliometric Indices from Scopus (updated December 2024)

Number of publications in international peer-reviewed journals               135

(first/last author)                                                                                           75 (56 %)

Impact Factor (Total)                                                                                    546

Impact Factor (Mean)                                                                                   4,3

Number of Citation (Total)                                                                           3863

Number of Citation (Mean)                                                                          28,7

Quoted in documents n°                                                                               2350

Hirsh Index                                                                                                    37